Weight that is hard to manage
Persistent appetite, increasing waist size or weight-related blood-pressure, lipid or glucose concerns.
Home / Clinical Peptide Therapy / Men
A men’s program · physician-crafted & managedLess hype. More medicine. We evaluate weight, sleep, energy, recovery and sexual-health concerns as connected parts of your health—then explain whether an evidence-based peptide medicine, another treatment or more testing makes sense.
Make the goal feel more tangible. Create a motivational AI visualization, then bring it to your consultation to discuss the health, energy, confidence and sustainable changes you want to work toward.
The Ageless preview opens in a new tab and is operated by a third party. Review its displayed privacy information before uploading a photograph or personal information.
Your body naturally uses peptides to signal cells. Certain prescription medicines imitate or modify specific signals—for example, appetite-related signals. That does not mean every peptide sold online is a medicine, or that vague symptoms prove you need one. Our role is to connect a defined problem to a treatment with credible evidence.
These are reasons to seek evaluation—not proof that peptide therapy is indicated.
Persistent appetite, increasing waist size or weight-related blood-pressure, lipid or glucose concerns.
These may signal obstructive sleep apnea, which requires proper diagnosis and a complete treatment plan.
Sleep loss, depression, anemia, thyroid problems, medication effects and metabolic disease may contribute.
Training load, injury, sleep, nutrition and medical conditions should be evaluated before blaming “low peptides.”
Sexual symptoms can reflect vascular, hormonal, medication, psychological or relationship factors and deserve targeted evaluation.
Age, inactivity, inadequate protein, weight loss and medical conditions matter. Unapproved peptides are not a safe shortcut to muscle gain.
A high-quality plan may involve sleep testing, cardiometabolic care, nutrition, resistance training, hormone evaluation or standard sexual-health treatment instead of—or in addition to—a peptide-based medicine.
This is not a complete eligibility list. A licensed clinician must review the current label and your individual history.
Trial averages do not predict an individual result.
STEP 1 reported 14.9% mean weight loss versus 2.4% with placebo, with lifestyle intervention, in adults with overweight or obesity without diabetes. Primary study.
SURMOUNT-1 reported mean loss across doses of 15.0% to 20.9% versus 3.1% with placebo. Gastrointestinal events were most common. Primary study.
Zepbound is FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity, together with reduced-calorie diet and increased physical activity. Diagnosis and ongoing sleep care still matter. Current FDA label.
Fatigue, low libido, reduced strength or erectile dysfunction do not by themselves diagnose testosterone deficiency. Professional guidance recommends diagnosing hypogonadism only when compatible symptoms are present and testosterone is unequivocally and consistently low on appropriate testing.
Symptoms, timeline, goals, prior efforts and health risks.
History, medications, vitals, labs and sleep evaluation when indicated.
Evidence, alternatives, FDA status, expectations and cost are discussed.
Response, body composition, strength, sleep and tolerability guide follow-up.
Learn the difference between FDA-approved, compounded and investigational products.
Visit the Clinical HubA distinct women’s pathway with life-stage, pregnancy and contraception considerations.
Explore the Women’s ProgramEvidence reviewed September 3, 2026 · Prepared under the Identity Aesthetics medical editorial standard. Educational content is not medical advice.
Book a men-focused clinical peptide consultation in office or ask whether telehealth is available for your location and needs.